Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be ...

Ascendis Pharma AS (ASND) reports significant milestones and market traction, despite facing revenue and reimbursement hurdles.

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

US President Donald Trump signed a Presidential memo on reciprocal tariffs to order his administration to investigate the ...

Explore the science behind why we always have room for dessert, even after a full meal, and the brain's sugar cravings.

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage ...

COPENHAGEN--Novo Nordisk will launch its hugely popular ... The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first ...